Commonwealth Equity Services
ITRM

Commonwealth Equity Services’s Iterum Therapeutics ITRM Stock Holding History

Commonwealth Equity Services’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,467
Closed -$12K – 3693
2021
Q3 		$12K Buy
1,467
+687
+88% +$8.46K ﹤0.01% 3560
2021
Q2 		$27K Sell
780
-453
-37% -$9.82K ﹤0.01% 3492
2021
Q1 		$26K Buy
+1,233
New +$29.4K ﹤0.01% 3368

Other funds holding ITRM

CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Commonwealth Equity Services's ITRM Position: Q4 2021 in Review

Commonwealth Equity Services sold out of Iterum Therapeutics (ITRM) in Q4 2021, closing a stake of 1,467 shares — an estimated $12K sold.

Commonwealth Equity Services first reported a position in ITRM in Q1 2021 and held it in 3 quarters. The position peaked at $27K in Q2 2021. 44 funds tracked by Wall St. Rank hold ITRM as of Q4 2021.

  • Commonwealth Equity Services reported no remaining Iterum Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,467 Iterum Therapeutics shares in Q4 2021, an estimated $12K.
  • Commonwealth Equity Services first reported a position in Iterum Therapeutics in Q1 2021 and held it in 3 quarters.
  • Commonwealth Equity Services's Iterum Therapeutics position peaked at $27K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q4 2021.

Based on Commonwealth Equity Services's 13F filing for Q4 2021, filed 31 Jan 2022.